ASX - By Stock
|
ID8 |
Re:
Ann: FY22 Annual Report Investor Update
|
|
Malzo
|
36 |
15K |
2 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
36
|
15K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
9 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
44K
|
21M
|
9
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: FY22 Annual Report Investor Update
|
|
Malzo
|
36 |
15K |
7 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
36
|
15K
|
7
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Drilling set to start at Lucky Sump spodumene prospect
|
|
Malzo
|
94 |
49K |
1 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
94
|
49K
|
1
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Drilling set to start at Lucky Sump spodumene prospect
|
|
Malzo
|
94 |
49K |
3 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
94
|
49K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
6 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
44K
|
21M
|
6
|
|
ASX - By Stock
|
PAL |
Re:
Ann: Removal from Official List
|
|
Malzo
|
3 |
2.4K |
2 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
3
|
2.4K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: CLARITY 2.0 COVID-19 Study Concludes Recruitment
|
|
Malzo
|
43 |
14K |
11 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
43
|
14K
|
11
|
|
ASX - By Stock
|
ID8 |
Re:
ID8 Chart
|
|
Malzo
|
251 |
82K |
5 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
251
|
82K
|
5
|
|
ASX - By Stock
|
ID8 |
Re:
ID8 Chart
|
|
Malzo
|
251 |
82K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
251
|
82K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DSMB Change to REMAP-CAP COVID-19 Study
|
|
Malzo
|
81 |
27K |
1 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
81
|
27K
|
1
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Mt York Spodumene Pegmatite Results
|
|
Malzo
|
179 |
87K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
179
|
87K
|
0
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Mt York Spodumene Pegmatite Results
|
|
Malzo
|
179 |
87K |
10 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
179
|
87K
|
10
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
13 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
44K
|
21M
|
13
|
|
ASX - By Stock
|
ID8 |
Re:
ID8 Chart
|
|
Malzo
|
251 |
82K |
1 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
251
|
82K
|
1
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda signs Binding Halloysite-Kaolin Offtake Term Sheet
|
|
Malzo
|
196 |
88K |
15 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
196
|
88K
|
15
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda signs Binding Halloysite-Kaolin Offtake Term Sheet
|
|
Malzo
|
196 |
88K |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
196
|
88K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Malzo
|
21 |
7.0K |
3 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
21
|
7.0K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Malzo
|
21 |
7.0K |
1 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
21
|
7.0K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Malzo
|
21 |
7.0K |
0 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
21
|
7.0K
|
0
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Spodumene-bearing pegmatite samples discovered at Mt York
|
|
Malzo
|
58 |
27K |
8 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
58
|
27K
|
8
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
44K
|
21M
|
3
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Spodumene-bearing pegmatite samples discovered at Mt York
|
|
Malzo
|
58 |
27K |
9 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
58
|
27K
|
9
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
11 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
44K
|
21M
|
11
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
20 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
44K
|
21M
|
20
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to Present at BIO International Convention
|
|
Malzo
|
27 |
9.8K |
2 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
27
|
9.8K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-700 Study Shows Significant 80% Reduction in Lung Injury
|
|
Malzo
|
51 |
19K |
5 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
51
|
19K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: REMAP-CAP COVID-19 Study Analysis Update
|
|
Malzo
|
76 |
24K |
3 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
76
|
24K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: REMAP-CAP COVID-19 Study Analysis Update
|
|
Malzo
|
76 |
24K |
6 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
76
|
24K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to Present at BIO International Convention
|
|
Malzo
|
27 |
9.8K |
2 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
27
|
9.8K
|
2
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
Malzo
|
60 |
20K |
0 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
60
|
20K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Option to sell Zambia Projects for GBP 2.25m plus milestone
|
|
Malzo
|
7 |
4.6K |
2 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
7
|
4.6K
|
2
|
|
ASX - By Stock
|
PAL |
Re:
Ann: Update to Shareholders
|
|
Malzo
|
4 |
3.1K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
4
|
3.1K
|
2
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Maiden MRE of 21,556t contained cobalt at Broken Hill
|
|
Malzo
|
44 |
15K |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
44
|
15K
|
1
|
|
ASX - By Stock
|
DRM |
Re:
Demetallica IPO
|
|
Malzo
|
173 |
49K |
2 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
173
|
49K
|
2
|
|
ASX - By Stock
|
KAI |
Re:
Ann: Trading Halt
|
|
Malzo
|
108 |
51K |
2 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
108
|
51K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
|
|
Malzo
|
49 |
21K |
0 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
49
|
21K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
2 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
44K
|
21M
|
2
|
|
ASX - By Stock
|
DRM |
Re:
What will Demetallica list at?
|
|
Malzo
|
38 |
9.7K |
1 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
38
|
9.7K
|
1
|
|
ASX - By Stock
|
DRM |
Re:
Demetallica IPO
|
|
Malzo
|
173 |
49K |
0 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
173
|
49K
|
0
|
|
ASX - By Stock
|
DRM |
Re:
What will Demetallica list at?
|
|
Malzo
|
38 |
9.7K |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
38
|
9.7K
|
1
|
|
ASX - By Stock
|
ID8 |
Re:
Broker data
|
|
Malzo
|
30 |
8.2K |
2 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
30
|
8.2K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
7 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
44K
|
21M
|
7
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Renounceable Rights Issue to Raise up to $6 Million
|
|
Malzo
|
95 |
52K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
95
|
52K
|
0
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Renounceable Rights Issue to Raise up to $6 Million
|
|
Malzo
|
95 |
52K |
1 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
95
|
52K
|
1
|
|
ASX - By Stock
|
ID8 |
Re:
Identitii (ASX:ID8): A unique opportunity at the forefront of the banking regulation revolution
|
|
Malzo
|
17 |
10K |
8 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
17
|
10K
|
8
|
|
ASX - By Stock
|
PAL |
Re:
Ann: Update to shareholders
|
|
Malzo
|
1 |
1.2K |
0 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
1
|
1.2K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Investor Presentation - Shareholder Webinar
|
|
Malzo
|
410 |
161K |
2 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
410
|
161K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DSMB Change to REMAP-CAP COVID-19 Study
|
|
Malzo
|
81 |
27K |
5 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
81
|
27K
|
5
|
|
ASX - By Stock
|
NAE |
Re:
lalalala
|
|
Malzo
|
13 |
5.9K |
1 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
13
|
5.9K
|
1
|
|